Suchergebnisse - "Dupilumab"

PubPharm (2.830)

61

Successful treatment of resistant Grover's disease with dupilumab

enthalten in: International journal of women's dermatology | 2024

von Kaprive, J. | Washburn, S. | Emerson, C. | +1

62

Advancements in biologic therapy in eosinophilic asthma

enthalten in: Expert opinion on biological therapy | 2024

von Patadia, R. | Casale, T. | Fowler, J. | +2

63

Diagnosis, management and therapeutic options for eosinophilic esophagitis

enthalten in: Current opinion in allergy and clinical immunology | 2024

von Caminati, M. | Senna, G. | Maule, M. | +2

64

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

enthalten in: Dermatology and therapy | 2024

von Torres, T. | Sohrt Petersen, A. | Ivens, U. | +3

65

Mandated step therapy for dupilumab delays the inevitable

enthalten in: The Journal of dermatological treatment | 2024

von Florenzo, B. | Lyons, C. | Smith, A. | +3

66

The treatment efficacy of dupilumab in autosomal dominant hyper-immunoglobulin E syndrome with severe atopic dermatitis

enthalten in: Asia Pacific allergy | 2024

von Li, W. | Qi, Q. | Wang, W. | +1

67

Dupilumab's impact on nasal citology : Real life experience after 1 year of treatment

enthalten in: American journal of otolaryngology | 2024

von Gelardi, M. | Giancaspro, R. | Quaranta, V. | +3

68

Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?

enthalten in: Journal of clinical medicine | 2024

von Ferrucci, S. | Tavecchio, S. | Ceresa, A. | +4

69

Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps

enthalten in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery | 2024

von Hopkins, C. | Mullol, J. | Khan, A. | +12

70

Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis'

enthalten in: Dermatology and therapy | 2024

von Bastian, M. | Freemantle, N. | Rossi, A. | +5

CommentOn: Dermatol Ther (Heidelb). 2024 Jan;14(1):169-182. - PMID 37897645